title: Commentary on late breaking trials in interventional cardiology at ESC, VIVA, TCT, AHA (Fall 2012), and ACC 2013.
abstract: With the plethora of clinical trials, it is difficult for busy interventional cardiologists to stay up to date. Therefore, the Society for Cardiovascular Angiography and Interventions (SCAI) publications committee concisely summarized and provided editorial commentary on the most important trials from recent, large international meetings. The intent is to provide this summary every six months to allow quick assimilation of trial results into interventional practice.
authors.affiliation: Stanford University Medical Center, Stanford, California.
authors.forename: Jennifer A
authors.initials: JA
authors.lastname: Tremmel
authors.forename: Rajan A G
authors.initials: RA
authors.lastname: Patel
authors.forename: Deepak L
authors.initials: DL
authors.lastname: Bhatt
authors.forename: Mehmet
authors.initials: M
authors.lastname: Cilingiroglu
authors.forename: Duane S
authors.initials: DS
authors.lastname: Pinto
authors.forename: Larry S
authors.initials: LS
authors.lastname: Dean
authors.forename: Cindy L
authors.initials: CL
authors.lastname: Grines
mesh_terms: D002309:Cardiology; D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*; D002986:Clinical Trials as Topic; D003226:Congresses as Topic; D006801:Humans; D012955:Societies, Medical; D016896:Treatment Outcome
keywords: antithrombotics; myocardial infarction; peripheral arterial disease; review; stents; valvular heart disease